Trinity Biotech (TRIB) Competitors

Trinity Biotech logo
$6.01 +0.63 (+11.71%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$5.71 -0.30 (-4.99%)
As of 07:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TRIB vs. CVRX, RVP, LFWD, SNWV, and MODD

Should you buy Trinity Biotech stock or one of its competitors? Trinity Biotech's main competitors and comparable companies include CVRx (CVRX), Retractable Technologies (RVP), Lifeward (LFWD), Sanuwave Health (SNWV), and Modular Medical (MODD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Trinity Biotech compare to CVRx?

Trinity Biotech (NASDAQ:TRIB) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

In the previous week, CVRx had 24 more articles in the media than Trinity Biotech. MarketBeat recorded 25 mentions for CVRx and 1 mentions for Trinity Biotech. Trinity Biotech's average media sentiment score of 1.77 beat CVRx's score of 0.00 indicating that Trinity Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Trinity Biotech
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
CVRx
1 Very Positive mention(s)
2 Positive mention(s)
19 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral

79.0% of Trinity Biotech shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 8.2% of Trinity Biotech shares are held by insiders. Comparatively, 16.6% of CVRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CVRx has a consensus price target of $2.70, indicating a potential upside of 341.90%. Given CVRx's stronger consensus rating and higher probable upside, analysts clearly believe CVRx is more favorable than Trinity Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trinity Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
CVRx
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Trinity Biotech has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trinity Biotech$43.78M0.11-$37.38M-$44.26N/A
CVRx$56.65M0.31-$53.31M-$2.01N/A

Trinity Biotech has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, CVRx has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

Trinity Biotech has a net margin of -70.06% compared to CVRx's net margin of -88.28%. Trinity Biotech's return on equity of 0.00% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
Trinity Biotech-70.06% N/A -32.13%
CVRx -88.28%-208.45%-55.42%

Summary

CVRx beats Trinity Biotech on 9 of the 15 factors compared between the two stocks.

How does Trinity Biotech compare to Retractable Technologies?

Trinity Biotech (NASDAQ:TRIB) and Retractable Technologies (NYSE:RVP) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

In the previous week, Retractable Technologies had 1 more articles in the media than Trinity Biotech. MarketBeat recorded 2 mentions for Retractable Technologies and 1 mentions for Trinity Biotech. Trinity Biotech's average media sentiment score of 1.77 beat Retractable Technologies' score of 0.00 indicating that Trinity Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Trinity Biotech
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Retractable Technologies has lower revenue, but higher earnings than Trinity Biotech. Retractable Technologies is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trinity Biotech$43.78M0.11-$37.38M-$44.26N/A
Retractable Technologies$33.90M0.50-$7.01M-$0.12N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trinity Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Trinity Biotech has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market.

79.0% of Trinity Biotech shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 8.2% of Trinity Biotech shares are owned by company insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Retractable Technologies has a net margin of -41.11% compared to Trinity Biotech's net margin of -70.06%. Trinity Biotech's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Trinity Biotech-70.06% N/A -32.13%
Retractable Technologies -41.11%-17.15%-9.33%

Summary

Retractable Technologies beats Trinity Biotech on 8 of the 13 factors compared between the two stocks.

How does Trinity Biotech compare to Lifeward?

Lifeward (NASDAQ:LFWD) and Trinity Biotech (NASDAQ:TRIB) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment.

Trinity Biotech has a net margin of -70.06% compared to Lifeward's net margin of -155.37%. Trinity Biotech's return on equity of 0.00% beat Lifeward's return on equity.

Company Net Margins Return on Equity Return on Assets
Lifeward-155.37% -295.75% -82.97%
Trinity Biotech -70.06%N/A -32.13%

Lifeward has higher earnings, but lower revenue than Trinity Biotech. Lifeward is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lifeward$22.03M0.40-$19.91M-$15.74N/A
Trinity Biotech$43.78M0.11-$37.38M-$44.26N/A

Lifeward has a beta of 0.55, meaning that its stock price is 45% less volatile than the broader market. Comparatively, Trinity Biotech has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

Lifeward currently has a consensus target price of $8.00, indicating a potential upside of 158.06%. Given Lifeward's stronger consensus rating and higher probable upside, equities analysts plainly believe Lifeward is more favorable than Trinity Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lifeward
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Trinity Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Lifeward had 4 more articles in the media than Trinity Biotech. MarketBeat recorded 5 mentions for Lifeward and 1 mentions for Trinity Biotech. Trinity Biotech's average media sentiment score of 1.77 beat Lifeward's score of -0.20 indicating that Trinity Biotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Lifeward
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Trinity Biotech
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are owned by institutional investors. 1.1% of Lifeward shares are owned by insiders. Comparatively, 8.2% of Trinity Biotech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Trinity Biotech beats Lifeward on 8 of the 15 factors compared between the two stocks.

How does Trinity Biotech compare to Sanuwave Health?

Trinity Biotech (NASDAQ:TRIB) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Sanuwave Health has a consensus price target of $47.00, indicating a potential upside of 2,664.71%. Given Sanuwave Health's stronger consensus rating and higher probable upside, analysts plainly believe Sanuwave Health is more favorable than Trinity Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trinity Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Sanuwave Health
2 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.67

Trinity Biotech has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market.

Sanuwave Health has a net margin of 6.22% compared to Trinity Biotech's net margin of -70.06%. Sanuwave Health's return on equity of 113.13% beat Trinity Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Trinity Biotech-70.06% N/A -32.13%
Sanuwave Health 6.22%113.13%7.17%

Sanuwave Health has higher revenue and earnings than Trinity Biotech. Sanuwave Health is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trinity Biotech$43.78M0.11-$37.38M-$44.26N/A
Sanuwave Health$44.05M0.33$11.81M-$0.38N/A

79.0% of Trinity Biotech shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 8.2% of Trinity Biotech shares are held by insiders. Comparatively, 14.4% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Sanuwave Health had 2 more articles in the media than Trinity Biotech. MarketBeat recorded 3 mentions for Sanuwave Health and 1 mentions for Trinity Biotech. Trinity Biotech's average media sentiment score of 1.77 beat Sanuwave Health's score of 0.18 indicating that Trinity Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Trinity Biotech
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Sanuwave Health
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Sanuwave Health beats Trinity Biotech on 13 of the 15 factors compared between the two stocks.

How does Trinity Biotech compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and Trinity Biotech (NASDAQ:TRIB) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

Modular Medical has higher earnings, but lower revenue than Trinity Biotech. Modular Medical is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$28.24M-$8.69N/A
Trinity Biotech$43.78M0.11-$37.38M-$44.26N/A

Modular Medical has a net margin of 0.00% compared to Trinity Biotech's net margin of -70.06%. Trinity Biotech's return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -292.14% -222.79%
Trinity Biotech -70.06%N/A -32.13%

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are owned by institutional investors. 2.3% of Modular Medical shares are owned by company insiders. Comparatively, 8.2% of Trinity Biotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Trinity Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Modular Medical had 1 more articles in the media than Trinity Biotech. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for Trinity Biotech. Trinity Biotech's average media sentiment score of 1.77 beat Modular Medical's score of 0.96 indicating that Trinity Biotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Modular Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Trinity Biotech
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Modular Medical has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, Trinity Biotech has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market.

Summary

Trinity Biotech beats Modular Medical on 7 of the 11 factors compared between the two stocks.

Get Trinity Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRIB vs. The Competition

MetricTrinity BiotechHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$4.37M$5.99B$7.83B$11.74B
Dividend YieldN/A1.68%2.47%4.47%
P/E Ratio-0.1438.0633.9728.44
Price / Sales0.115.398.495.70
Price / CashN/A23.6221.0121.90
Price / Book-0.014.174.453.72
Net Income-$37.38M$143.92M$3.52B$393.10M
7 Day Performance6.18%-5.44%-5.94%-5.77%
1 Month Performance-25.16%-3.64%-4.58%-7.14%
1 Year Performance-75.67%-0.05%-1.95%-7.47%

Trinity Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRIB
Trinity Biotech
1.5033 of 5 stars
$6.01
+11.7%
N/A-75.5%$4.37M$43.78MN/A287
CVRX
CVRx
3.126 of 5 stars
$0.70
-10.3%
$3.30
+371.4%
-93.4%$18.65M$56.65MN/A223
RVP
Retractable Technologies
N/A$0.56
-0.5%
N/A-32.2%$16.68M$33.90MN/A201
LFWD
Lifeward
2.0227 of 5 stars
$5.89
-0.8%
$10.00
+69.8%
-56.6%$16.67M$22.03MN/A81
SNWV
Sanuwave Health
1.9761 of 5 stars
$1.95
+5.6%
$47.00
+2,305.3%
-94.8%$16.50M$44.05M8.0055

Related Companies and Tools


This page (NASDAQ:TRIB) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners